BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 17031243)

  • 1. Effects of histologic type on levels of macrophage colony-stimulating factor in liquid contents of benign ovarian tumors.
    Hayashi M; Shibazaki M; Sohma R; Inaba N
    Am J Med Sci; 2006 Oct; 332(4):181-5. PubMed ID: 17031243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of combined use of macrophage colony-stimulating factor and squamous cell carcinoma antigen as a selective diagnostic marker for squamous cell carcinoma arising in mature cystic teratoma of the ovary.
    Suzuki M; Tamura N; Kobayashi H; Ohwada M; Terao T; Sato I
    Gynecol Oncol; 2000 Jun; 77(3):405-9. PubMed ID: 10831350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Macrophage-colony stimulating factor and ovarian cancer].
    Menditto A; Piscittelli V; Cassese F; Balbi GC; Balbi C; Cardone A
    Minerva Ginecol; 1999; 51(7-8):261-4. PubMed ID: 10536419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrophage colony-stimulating factor as a marker for malignant germ cell tumors of the ovary.
    Suzuki M; Kobayashi H; Ohwada M; Terao T; Sato I
    Gynecol Oncol; 1998 Jan; 68(1):35-7. PubMed ID: 9454657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine production profiles in the peritoneal fluids of patients with malignant or benign gynecologic tumors.
    Punnonen R; Teisala K; Kuoppala T; Bennett B; Punnonen J
    Cancer; 1998 Aug; 83(4):788-96. PubMed ID: 9708947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovarian mature teratomas with mucinous epithelial neoplasms: morphologic heterogeneity and association with pseudomyxoma peritonei.
    McKenney JK; Soslow RA; Longacre TA
    Am J Surg Pathol; 2008 May; 32(5):645-55. PubMed ID: 18344868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Granulosa cell tumor and mucinous cystadenoma arising in a mature cystic teratoma of the ovary: A unique case report and review of literature.
    Moid FY; Jones RV
    Ann Diagn Pathol; 2004 Apr; 8(2):96-101. PubMed ID: 15060888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coexisting ovarian serous cystadenoma with fibroma: A very unusual combination.
    Balhara K; Mallya V; Khurana N; Tempe A
    J Cancer Res Ther; 2023; 19(5):1474-1476. PubMed ID: 37787335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mature cystic teratoma of the ovary associated with complete colonic wall and mucinous cystadenoma.
    Tang P; Soukkary S; Kahn E
    Ann Clin Lab Sci; 2003; 33(4):465-70. PubMed ID: 14584762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucinous cystadenoma, serous cystadenoma and benign cystic teratoma of the ovary: clinico-pathologic differences observed in a Malaysian hospital.
    Ong HC; Chan WF
    Cancer; 1978 Apr; 41(4):1538-42. PubMed ID: 639009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hematopoietic cytokines as tumor markers in gynecological malignancies. A multivariate analysis in epithelial ovarian cancer patients.
    Lawicki S; Gacuta-Szumarska E; Będkowska GE; Szmitkowski M
    Growth Factors; 2012 Dec; 30(6):357-66. PubMed ID: 22988839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage colony-stimulating factor as a tumor marker for epithelial ovarian cancer.
    Suzuki M; Ohwada M; Aida I; Tamada T; Hanamura T; Nagatomo M
    Obstet Gynecol; 1993 Dec; 82(6):946-50. PubMed ID: 8233270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucosal Proliferations in Completely Examined Fallopian Tubes Accompanying Ovarian Low-grade Serous Tumors: Neoplastic Precursor Lesions or Normal Variants of Benign Mucosa?
    Wolsky RJ; Price MA; Zaloudek CJ; Rabban JT
    Int J Gynecol Pathol; 2018 May; 37(3):262-274. PubMed ID: 28700429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histologic pattern, bilaterality and clinical evaluation of 957 ovarian neoplasms: a 10-year study in a tertiary hospital of eastern India.
    Mondal SK; Banyopadhyay R; Nag DR; Roychowdhury S; Mondal PK; Sinha SK
    J Cancer Res Ther; 2011; 7(4):433-7. PubMed ID: 22269405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the macrophage colony-stimulating factor and its receptor in gynecologic malignancies.
    Baiocchi G; Kavanagh JJ; Talpaz M; Wharton JT; Gutterman JU; Kurzrock R
    Cancer; 1991 Feb; 67(4):990-6. PubMed ID: 1825026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accuracy of intraoperative frozen section for the evaluation of ovarian neoplasms: an institutional experience.
    Hashmi AA; Naz S; Edhi MM; Faridi N; Hussain SD; Mumtaz S; Khan M
    World J Surg Oncol; 2016 Mar; 14():91. PubMed ID: 27029917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PAX2 and PAX8 reliably distinguishes ovarian serous tumors from mucinous tumors.
    Wang M; Ma H; Pan Y; Xiao W; Li J; Yu J; He J
    Appl Immunohistochem Mol Morphol; 2015 Apr; 23(4):280-7. PubMed ID: 24992169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ruptured cystic teratoma associated with mucinous cystadenoma in a pregnant woman.
    Aydin O; Pehlivanli F; Karaca G; Aydin G; Sayan CD; Atasoy P; Daphan CE
    Niger J Clin Pract; 2019 Apr; 22(4):578-581. PubMed ID: 30975966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial growth factor in ovarian cyst fluid.
    Boss EA; Massuger LF; Thomas CM; Geurts-Moespot A; Boonstra H; Sweep CG
    Cancer; 2001 Jan; 91(2):371-7. PubMed ID: 11180084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Coexistence of Two Different Epithelial Ovarian Tumors: A Rare Case.
    Topaloğlu ÖF; Uysal E; Çelik ZE; Çelik Ç
    Curr Med Imaging; 2022; 18(4):421-424. PubMed ID: 34503421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.